期刊文献+

肝移植治疗Wilson病8例分析 被引量:2

Liver transplantation in treatment of Wilson's disease: a report of 8 cases
在线阅读 下载PDF
导出
摘要 目的探讨Wilson病患者接受肝移植治疗后的效果及预后。方法回顾性分析2002年10月-2008年8月因Wilson病在第二军医大学附属东方肝胆外科医院接受肝移植手术的8例患者的临床资料,其中男3例,女5例,年龄为12~42岁,平均年龄为(22.6±10.3)岁。术前所有患者的血清铜蓝蛋白和血铜水平均低于正常值(血清铜蓝蛋白为200~600mg/L,血铜为11~24.4μmol/L),其中5例术前存在神经病学症状。结果 5例患者接受原位肝移植术,3例接受活体肝移植术。除1例患者于术后1个月死于急性肝脂肪变肝功能衰竭外,其余患者术后肝功能均恢复顺利。术后随访35~124个月,平均随访时间为(79.7±20.3)个月。与术前比较,术后1个月7例存活患者总胆红素水平显著下降(P<0.05),白蛋白、血清铜蓝蛋白水平及血小板计数均显著升高(P值均<0.05);血铜水平有升高趋势,但差异无统计学意义(P>0.05);合并的神经病学症状得到不同程度的改善甚至消失;所有患者术后12个月内K-F环均消失。结论通过全肝移植或活体肝移植术,能改善Wilson病患者铜代谢,并可显著缓解神经病学症状。 Objeetive To determine the efficacy and prognosis of liver transplantation for Wilson' s disease (WD). Methods From October 2002 to August 2008, 8 cases (3 men and 5 women) with a mean age of 22.6 years (12- 42 years) underwent liver transplantation for WD in our department. All the recipients had low serum levels of ceruloplasmin and copper before transplantation, and 5 of them demonstrated the neurological manifestations. Results There were 3 orthotopic liver transplantation (OLT) and 2 living donor liver transplantation (LDLT) in this study. Seven recipients recovered satisfactorily with excellent liver functions, while 1 patient died of acute liver steatosis in 1 month after transplantation. Discharged patients were well followed up for a mean duration of 79.7 months (35 - 124 months). Compared to the levels before transplantation, the total bilirubin levels were significantly declined (P〈 0. 05), the serum levels of albumin, ceruloplasmin and platelet were obviously increased (all P〈0.05), while that of copper was increased though no significant difference was found (P〉0.05). The neurological manifestations were also partly relieved or disappeared after liver transplantation. No K-P loop was found in the patients 12 months after operation. Conclusion OLT and LRLT are effective treatments for patients with WD,which not only improving their copper metabolism but also significantly relieving the severe neurological manifestations and improving life quality. (Shanghai Med J, 2011, 34; 656-659)
出处 《上海医学》 CAS CSCD 北大核心 2011年第9期656-659,共4页 Shanghai Medical Journal
基金 上海市科学技术委员会医学引导项目(10411963200)
关键词 原位肝移植 活体肝移植 WILSON病 Orthetopic liver transplantations Living donor liver transplantations Wilson's disease
作者简介 通信作者:杨宁,电子邮箱为lancet829@gmail.com
  • 相关文献

参考文献4

二级参考文献51

  • 1吴志英,王柠,慕容慎行,林珉婷.Identification and analysis of mutations of the Wilson disease gene in Chinese population[J].Chinese Medical Journal,2000(1):40-43. 被引量:9
  • 2Schilsky ML,scheinberg IH,Sternlied I.Liver transplantation for Wilson's disease:Imdications and outcome[J].Hepatology,1994,19:583-587
  • 3Geissler I,Heinemann K,Rohm S,et al.Liver transplantation for hepatic and neurological Wilson's disease[J].Transplant Proc,2003,35:1445-1446
  • 4Schumacher G,Platz KP,Mueller AR,et al.Liver transpantation in neurologyic Wilson's disease[J].Transplant Proc,2001,33:1518-1519
  • 5Sutcliffe RP,Maguire DD,Muiesan P,et al.Liver transplantaion,for Wilson's Disease:long-term results and quality-of-life assessment[J].Transplantation,2003,75:1003-1006
  • 6Guarino M,Stracciari A,Pazzaglia P,et al.Neurological complications of liver transplantation[J].J Neurol,1996,243:137-142
  • 7Shimizu N,Yanaguchi Y,Aoki T.Treatment and management of Wilson's disease[J].Pediatr Int 1999,41:419-422
  • 8Brewer GJ,Turkay A,Yuzbasiyan-Gurkan V.Development of neurologic symptoms in a patient with asymptomaitc Wilson's disease treated with Penicillamine[J].Arch Neurol,1994,51:304-305
  • 9Paul AC,Varkki S,Yohannan NB,et al.Neurological deterioration in a child with Wilson's disease on Penicillamine therapy[J].Indian J Gastroenterol,2003,22:104-105
  • 10Askari FK,Greenson J,Dick RD,et al.Treatment of Wilson's disease with zinc.XVⅢ.Initial treatment of the hepatic decompensation presentation with tritine and zinc[J].J Lab Clin Med,2003,142:385-390

共引文献43

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部